The largest database of trusted experimental protocols

Fibroblast growth factor 2 (fgf2)

Manufactured by ProSpec
Sourced in Israel, United States

FGF2 is a recombinant human Fibroblast Growth Factor 2 (basic FGF) protein. It is a heparin-binding growth factor that stimulates endothelial cell growth, nerve cell proliferation and survival.

Automatically generated - may contain errors

21 protocols using fibroblast growth factor 2 (fgf2)

1

FGF-2 Release Kinetics from Scaffolds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Basic fibroblast growth factor, also known as FGF-2, was loaded onto the scaffolds and the release profiles of FGF-2 were evaluated to determine the release kinetics of the scaffolds. FGF-2 (ProSpec-Tany TechnoGene, Rehovot, Israel) was mixed with distilled water to achieve a concentration of 500 ng/mL. The various scaffolds were then immersed in the FGF-2 solution for 2 h, for loading of FGF-2. After which, the scaffolds were immersed in medium at 37 °C for various durations to evaluate release profiles of FGF-2 using an enzyme-linked immunosorbent assay (ELISA) kit (Invitrogen, Carlsbad, CA, USA). The concentration was quantified using absorbances measured using a spectrophotometer. Finally, influence of the FGF-2-loaded scaffolds on cell proliferation and osteogenesis was also evaluated.
+ Open protocol
+ Expand
2

Soft Agar Assay for Cell Transformation

Check if the same lab product or an alternative is used in the 5 most similar protocols
JB6 P+ cells were plated at 500 cells/well (or otherwise indicated) in a 24-well plate in 200 µL of MEM media with 10% FBS in 0.33% agar overlaid onto 350 µL of MEM media with 10% FBS in 0.5% agar. FGF2 (Prospec, CYT-386) was incubated with the cells at 0.5 ng/mL and compared to untreated controls. Soft agar plates were left at room temperature for 30 minutes then incubated at 37 °C.
MCF-10A cells were seeded at 750 cells/well (or otherwise indicated) in a 24-well plate in 200 µL of DMEM/Ham’s F12, 5% HS, and 0.33% agar overlaid onto 350 µL of DMEM/Ham’s F12, 5% HS, and 0.5% agar. FGF2 (prospec, CYT-386) was incubated with the cells at 20 ng/mL and compared to untreated controls. Soft agar plates were left at room temperature for 30 minutes before 200 µL of MCF-10A growth media was gently added to each well and then stored at 37 °C. Every 3–4 days, the growth media was removed from each well and replenished with 200 µL of MCF-10A growth media.
After two weeks, JB6 P+ and MCF-10A soft agar plates were fixed in 70% ethanol (EtOH) and stained with 150 µL of 0.01% crystal violet. Colonies were visually counted and used to calculate the percent of colony formation from the number of cells plated ([Colonies counted × 100]/number of cells plated).
+ Open protocol
+ Expand
3

Epicardial Response to Developmental Signals

Check if the same lab product or an alternative is used in the 5 most similar protocols
PE HH17 explants and HH24 embryonic epicardial primary cultures were treated for 24 h with Bmp2, Bmp4, Fgf2, Fgf8 and thymosin beta 4 (Prospec, East Brunswick, NJ, USA), respectively, as reported by Hinkel et al.29 . Tissue explants were collected and processed according for qPCR and/or immunohistochemistry. Each experimental condition was carried out in isolated tissues from at least 30 embryos. In all cases, 3–5 independent biological replicates were analyzed.
+ Open protocol
+ Expand
4

Isolation and Culture of Primary BMDMs and AVICs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary BMDMs isolated from Mye-CCN3-KO or control mice were cultured in DMEM with 10% fetal bovine serum containing 4.5 mg/mL glucose, 1% penicillin/streptomycin, and 1% glutamine. Human Aortic Valve Interstitial Cells (AVICs) were isolated from donated hearts not suitable for transplant (LifeLink of Georgia) as previously described [23 (link), 24 (link)]. AVICs were cultured in DMEM supplemented with 1.0 mg/ml glucose,10% fetal bovine serum, 1% penicillin/streptomycin, 2 ng/ml basic fibroblast growth factor 2 (FGF2, Prospecbio, CYT-218) and 10 units/ml Heparin (Sigma, H7405-1G) and seeded on gelatin-coated glass-based dishes when not plated for experiments. Passages 4–7 were used for vitro assays. All cells were kept in a humidified incubator with 5% CO2 at 37 °C.
+ Open protocol
+ Expand
5

Rat Bone Marrow Mesenchymal Stem Cell Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow derived MSCs were isolated from the femoral shaft of 6 week old rats (Fischer Male) and expanded in high-glucose Dulbecco's modified Eagle's medium GlutaMAX (hgDMEM) supplemented with 10% v/v fetal bovine serum (FBS), 100 U/ml penicillin, 100 μg/ml streptomycin (all Gibco Biosciences, Dublin, Ireland) and 2.5 μg/ml amphotericin B (Sigma-Aldrich, Dublin, Ireland) at 5% pO2. Following colony formation, MSCs were trypsinized, counted, seeded at density of 5000 cells cm 2 in 500 cm 2 triple flasks (Thermo Fisher Scientific), supplemented with hgDMEM, 10% v/v FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 2.5 μg/ml amphotericin B, and 5 ng/ml human fibroblastic growth factor-2 (FGF-2; Prospec-Tany TechnoGene Ltd., Israel) and expanded to passage 2 at 5% pO2.
+ Open protocol
+ Expand
6

Sphere Formation from Neuroblastoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
SK-N-BE(2), IMR-5 and IMR-32 cells were grown for sphere formation in serum-free neurobasal medium (Invitrogen), supplemented with B27 (Invitrogen), 2 mM L-glutamine (Invitrogen), 20 ng/ml EGF (ProSpec-Tany Technogene Ltd, Ness-Ziona, Israel), 20 ng/ml FGF2 (ProSpec-Tany Technogene Ltd), 20 U/ml penicillin and 20 μg/ml streptomycin.
+ Open protocol
+ Expand
7

Differentiation of Pancreatic Progenitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
GPC were obtained by the protocol reported for Rezania et al. [15 (link)] with modifications. The protocol consists of 6 stages: stage 1, incubated for 4 days with RPMI 1640 (Gibco™. Catalog number 31800), bovine serum albumin (BSA) (Sigma-Aldrich, catalog number A9418) 2%, activin A 100 ng/mL (Prospecbio), Wnt3a 20 ng/mL (Sigma-Aldrich. Catalog number H17001), FGF2 8 ng/mL (Prospecbio. Catalog number CYT-085). Stage 2, incubated for 2 days with DMEM-F12 medium with BSA 2%, FGF7 50 ng/mL (Prospecbio. Catalog number CYT-303), Cyclopamine-KAAD 0.25 µM (SCBT, Dallas, Tx, USA. Catalog number sc-200929). Stage 3, incubation for 4 days with DMEM-F12 medium, Cyclopamin-KAAD 0.25 µM, retinoic acid (RA) 2 µM (Sigma-Aldrich. Catalog number R2625), FGF7 50 ng/mL (Prospecbio), Noggin 100 ng/mL (Prospecbio. Catalog number CYT-475). Stage 4, incubation for 3 days with DMEM:F12 medium, Inhibitor II ALK5 1 µM (SCBT. Catalog number sc-221234), Noggin 100 ng/mL, DAPT 1 µM (SCBT. Catalog number sc-201315). Stage 5, incubation for 7 days with DMEM/F12 medium, inhibitor II ALK5 1 µM. Stage 6, incubation for 7 days with DMEM F12 medium. However, we used 2% v/v FBS instead of 1% B27 as a supplement to differentiation medium during stages 3 to 6, Fig. 1b.
+ Open protocol
+ Expand
8

Isolation and Expansion of Porcine MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow derived MSCs were isolated from the femoral shaft of 4 month old pigs and expanded as previously described [38] . Tri-potentiality was confirmed prior to use. Following colony formation, MSCs were trypsinized, counted, seeded at density of 5000 cells cm 2 in 500 cm 2 triple flasks (Thermo Fisher Scientific), supplemented with hgDMEM, 10% v/v FBS, 100 U ml -1 penicillin/100 μg ml -1 streptomycin, 2.5 μg ml -1 amphotericin B and 5 ng ml -1 human fibroblastic growth factor-2 (FGF-2; Prospec-Tany TechnoGene Ltd., Israel) and expanded to passage 2. Separate donors were isolated for study 1, 2 & 3.
+ Open protocol
+ Expand
9

Naive Human ESC Line Maintenance

Check if the same lab product or an alternative is used in the 5 most similar protocols
Elf1 cells, a naïve human ESC line isolated from an 8-cell human embryo, were procured from Wicell (Madison, WI, USA) and maintained according to a previously published protocol [22 (link)]. Briefly, Elf1 cells were grown adherent to mouse embryonic feeder (MEF) coated 6-well plates and incubated in a medium containing KnockOut/F12 DMEM with GlutaMax (Life Technologies, Carlsbad, CA, USA) with 20% KnockOut serum replacement (Life Technologies), 1 mM sodium pyruvate (Life Technologies), 0.1 mM 2-Mercaptoehtanol (Life Technologies), 1% non-essential amino acids (Life Technologies), and 0.2% penicillin-streptomycin solution (Life Technologies), and supplemented with 12 ng/mL FGF2 (Prospec, Ness Ziona, Israel), 1.5 μM CHIR99021 (Cayman Chemical, Ann Arbor, MI, USA), 0.4 μM PD03296501 (Caymen Chemical) and 0.01 μg/mL human LIF (Prospec). Prior to encapsulation in 3-D scaffolds, cells were transitioned to feeder-free culture in Matrigel-coated 6-well plates (Fisher Scientific, Pittsburgh, PA, USA).
+ Open protocol
+ Expand
10

Melanosphere Culture from Single Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 500 single viable cells (TVM-A12 and TVM-A12-CD133+) were seeded into 48-well tissue culture plates coated with 0.5 mg/ml of poly-2-hydroxyethyl methacrylate (Poly-HEMA, Sigma) in a 500 μl of serum-free DMEM/F12 (1:1) (Sigma) basal medium supplemented with L-glutamine (2 mM), Penicillin-Streptomycin (100 mg/ml), 20 ng/ml human epidermal growth factor (EGF) 20 ng/ml, human fibroblast growth factor-2 (FGF-2) (ProSpec, Rehovot, Israel), and 1:50 B-27 supplement (Gibco, Life Technologies, Carlsbad, CA, USA) and cultured at 37 °C in a humidified 5% CO2 for 10 days to form melanospheres. For serial passage, these melanospheres were counted using a manually prepared “quadrant grid” under microscopic observation, harvested and centrifuged at 1000 rpm for 5 min, trypsinized to dissociate in to single cell, counted and viable cells reseeded in the Poly-HEMA coated 48-well plates for subsequent passages.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!